Centrifugal microfluidics belongs to a branch of microfluidics, which refers to the control of microfluidics by centrifugal force to drive liquid flow. It integrates the basic operations involved in biology and chemistry on a small disc-shaped chip, so it is also called Lab-on-a-Disc (LOAD).

General Electric’s board of directors approved its planned spin off of its healthcare business. The new firm, called GE HealthCare, is expected to start trading on Nasdaq on Jan. 4., under the ticker “GEHC.”

KSL Pulse Scientific said Tuesday it will distribute Lucira Health's disposable molecular test for COVID-19 and influenzas A and B for over-the-counter use in Canada.

On Dec. 1st, Sansure announced that its bordetella pertussis nucleic acid test kit (PCR-fluorescent probe method) obtained the certificate approved by NMPA.

HemoSonics said Wednesday it secured US Food and Drug Administration 510(k) clearance for the company's QStat Cartridge assay to provide point-of-care hemostasis data during trauma and liver transplantation procedures.

Ceres Nanosciences said on Thursday that it has received $1.4 million in new funding from the National Institutes of Health RADx initiative to expand a network of wastewater-based epidemiology centers of excellence that was established with $8.2 million in prior RADx funding.

Autobio’s Autolas X-1 Series intelligent online refrigerator is different from the traditional offline refrigerator, it is no longer a simple cold storage, but an intelligent management system for specimens.

The US Food and Drug Administration on Tuesday expanded its library of guidance for monkeypox test developers by releasing two templates for development of antigen tests for monkeypox infection, following the publication earlier this year of a pair of templates for molecular test development.

Amid what it called an online barrage of “racist and stigmatizing language” about monkeypox, the World Health Organization said on Monday it will begin using a new preferred term “mpox” as a synonym for the disease.

CAIRE Inc., a subsidiary of NGK SPARK PLUG CO., LTD., will acquire St. Paul, Minnesota-based MGC Diagnostics Holdings, Inc. (MGC).

On November 28th China Biologics public release said that the company's anti-neoconazole monoclonal antibody F61 nasal spray developed by the company was approved for clinical use.

Liquid biopsy firm SeekIn said Monday that it has received a CE mark for its cancer recurrence monitoring test, SeekInCure, and is preparing to launch assay kits in the European Union and other countries that recognize the designation.

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

According to the WeChat public account of Peking Union Medical College Hospital on November 21, the peripheral blood cell image leukocyte assisted recognition software jointly developed by the Laboratory Department of Peking Union Medical College Hospital and Beijing Xiaofly Technology passed

Cue Health on Wednesday afternoon announced that revenues for the third quarter beat both Wall Street expectations and previous guidance from the firm.